Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.

JACC. Basic to translational science

Torzewski M, Ravandi A, Yeang C, Edel A, Bhindi R, Kath S, Twardowski L, Schmid J, Yang X, Franke UFW, Witztum JL, Tsimikas S.
PMID: 29147686
JACC Basic Transl Sci. 2017 Jun;2(3):229-240. doi: 10.1016/j.jacbts.2017.02.004. Epub 2017 Jun 26.

The

Cite
Torzewski M, Ravandi A, Yeang C, et al. Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. JACC Basic Transl Sci. 2017;2(3):229-240doi: 10.1016/j.jacbts.2017.02.004.
Torzewski, M., Ravandi, A., Yeang, C., Edel, A., Bhindi, R., Kath, S., Twardowski, L., Schmid, J., Yang, X., Franke, U. F. W., Witztum, J. L., & Tsimikas, S. (2017). Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. JACC. Basic to translational science, 2(3), 229-240. https://doi.org/10.1016/j.jacbts.2017.02.004
Torzewski, Michael, et al. "Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis." JACC. Basic to translational science vol. 2,3 (2017): 229-240. doi: https://doi.org/10.1016/j.jacbts.2017.02.004
Torzewski M, Ravandi A, Yeang C, Edel A, Bhindi R, Kath S, Twardowski L, Schmid J, Yang X, Franke UFW, Witztum JL, Tsimikas S. Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis. JACC Basic Transl Sci. 2017 Jun;2(3):229-240. doi: 10.1016/j.jacbts.2017.02.004. Epub 2017 Jun 26. PMID: 29147686; PMCID: PMC5685511.
Copy Download .nbib Format: NLM
Author Correction: Inflammation-induced IgA.

Nature

Shalapour S, Lin XJ, Bastian IN, Brain J, Burt AD, Aksenov AA, Vrbanac AF, Li W, Perkins A, Matsutani T, Zhong Z, Dhar D, Navas-Molina JA, Xu J, Loomba R, Downes M, Yu RT, Evans RM, Dorrestein PC, Knight R, Benner C, Anstee QM, Karin M.
PMID: 29973714
Nature. 2018 Sep;561(7721):E1. doi: 10.1038/s41586-018-0304-y.

In this Article, the sentence: "After 7 months of HFD, MUP-uPA mice developed HCC

Cite
Shalapour S, Lin XJ, Bastian IN, et al. Author Correction: Inflammation-induced IgA. Nature. 2018;561(7721):E1doi: 10.1038/s41586-018-0304-y.
Shalapour, S., Lin, X. J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., Zhong, Z., Dhar, D., Navas-Molina, J. A., Xu, J., Loomba, R., Downes, M., Yu, R. T., Evans, R. M., Dorrestein, P. C., Knight, R., Benner, C., Anstee, Q. M., & Karin, M. (2018). Author Correction: Inflammation-induced IgA. Nature, 561(7721), E1. https://doi.org/10.1038/s41586-018-0304-y
Shalapour, Shabnam, et al. "Author Correction: Inflammation-induced IgA." Nature vol. 561,7721 (2018): E1. doi: https://doi.org/10.1038/s41586-018-0304-y
Shalapour S, Lin XJ, Bastian IN, Brain J, Burt AD, Aksenov AA, Vrbanac AF, Li W, Perkins A, Matsutani T, Zhong Z, Dhar D, Navas-Molina JA, Xu J, Loomba R, Downes M, Yu RT, Evans RM, Dorrestein PC, Knight R, Benner C, Anstee QM, Karin M. Author Correction: Inflammation-induced IgA. Nature. 2018 Sep;561(7721):E1. doi: 10.1038/s41586-018-0304-y. PMID: 29973714; PMCID: PMC7871211.
Copy Download .nbib Format: NLM
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Cell metabolism

Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin CB, Schnabl B, Brinkac L, Schork N, Chen CH, Brenner DA, Biggs W, Yooseph S, Venter JC, Nelson KE.
PMID: 31484056
Cell Metab. 2019 Sep 03;30(3):607. doi: 10.1016/j.cmet.2019.08.002.

No abstract available.

Cite
Loomba R, Seguritan V, Li W, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2019;30(3):607doi: 10.1016/j.cmet.2019.08.002.
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., Jones, M. B., Sirlin, C. B., Schnabl, B., Brinkac, L., Schork, N., Chen, C. H., Brenner, D. A., Biggs, W., Yooseph, S., Venter, J. C., & Nelson, K. E. (2019). Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell metabolism, 30(3), 607. https://doi.org/10.1016/j.cmet.2019.08.002
Loomba, Rohit, et al. "Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease." Cell metabolism vol. 30,3 (2019): 607. doi: https://doi.org/10.1016/j.cmet.2019.08.002
Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin CB, Schnabl B, Brinkac L, Schork N, Chen CH, Brenner DA, Biggs W, Yooseph S, Venter JC, Nelson KE. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metab. 2019 Sep 03;30(3):607. doi: 10.1016/j.cmet.2019.08.002. PMID: 31484056; PMCID: PMC8025688.
Copy Download .nbib Format: NLM
Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.

Nature medicine

Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, Evans RM, Xu Y, Chen HW.
PMID: 27270780
Nat Med. 2016 Jun 07;22(6):692. doi: 10.1038/nm0616-692b.

No abstract available.

Cite
Wang J, Zou JX, Xue X, et al. Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nat Med. 2016;22(6):692doi: 10.1038/nm0616-692b.
Wang, J., Zou, J. X., Xue, X., Cai, D., Zhang, Y., Duan, Z., Xiang, Q., Yang, J. C., Louie, M. C., Borowsky, A. D., Gao, A. C., Evans, C. P., Lam, K. S., Xu, J., Kung, H. J., Evans, R. M., Xu, Y., & Chen, H. W. (2016). Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nature medicine, 22(6), 692. https://doi.org/10.1038/nm0616-692b
Wang, Junjian, et al. "Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer." Nature medicine vol. 22,6 (2016): 692. doi: https://doi.org/10.1038/nm0616-692b
Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, Evans RM, Xu Y, Chen HW. Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nat Med. 2016 Jun 07;22(6):692. doi: 10.1038/nm0616-692b. PMID: 27270780.
Copy Download .nbib Format: NLM
Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production.

Science (New York, N.Y.)

Orecchioni M, Kobiyama K, Winkels H, Ghosheh Y, McArdle S, Mikulski Z, Kiosses WB, Fan Z, Wen L, Jung Y, Roy P, Ali AJ, Miyamoto Y, Mangan M, Makings J, Wang Z, Denn A, Vallejo J, Owens M, Durant CP, Braumann S, Mader N, Li L, Matsunami H, Eckmann L, Latz E, Wang Z, Hazen SL, Ley K.
PMID: 35025664
Science. 2022 Jan 14;375(6577):214-221. doi: 10.1126/science.abg3067. Epub 2022 Jan 13.

[Figure: see text].

Cite
Orecchioni M, Kobiyama K, Winkels H, et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science. 2022;375(6577):214-221doi: 10.1126/science.abg3067.
Orecchioni, M., Kobiyama, K., Winkels, H., Ghosheh, Y., McArdle, S., Mikulski, Z., Kiosses, W. B., Fan, Z., Wen, L., Jung, Y., Roy, P., Ali, A. J., Miyamoto, Y., Mangan, M., Makings, J., Wang, Z., Denn, A., Vallejo, J., Owens, M., Durant, C. P., Braumann, S., Mader, N., Li, L., Matsunami, H., Eckmann, L., Latz, E., Wang, Z., Hazen, S. L., & Ley, K. (2022). Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science (New York, N.Y.), 375(6577), 214-221. https://doi.org/10.1126/science.abg3067
Orecchioni, Marco, et al. "Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production." Science (New York, N.Y.) vol. 375,6577 (2022): 214-221. doi: https://doi.org/10.1126/science.abg3067
Orecchioni M, Kobiyama K, Winkels H, Ghosheh Y, McArdle S, Mikulski Z, Kiosses WB, Fan Z, Wen L, Jung Y, Roy P, Ali AJ, Miyamoto Y, Mangan M, Makings J, Wang Z, Denn A, Vallejo J, Owens M, Durant CP, Braumann S, Mader N, Li L, Matsunami H, Eckmann L, Latz E, Wang Z, Hazen SL, Ley K. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science. 2022 Jan 14;375(6577):214-221. doi: 10.1126/science.abg3067. Epub 2022 Jan 13. PMID: 35025664.
Copy Download .nbib Format: NLM
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis.

Cell metabolism

Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, Singh S, Madamba EV, Bettencourt R, Richards L, Yu RT, Atkins AR, Huan T, Brenner DA, Sirlin CB, Downes M, Evans RM, Loomba R.
PMID: 33147487
Cell Metab. 2020 Nov 03;32(5):901. doi: 10.1016/j.cmet.2020.10.015.

No abstract available.

Cite
Oh TG, Kim SM, Caussy C, et al. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell Metab. 2020;32(5):901doi: 10.1016/j.cmet.2020.10.015.
Oh, T. G., Kim, S. M., Caussy, C., Fu, T., Guo, J., Bassirian, S., Singh, S., Madamba, E. V., Bettencourt, R., Richards, L., Yu, R. T., Atkins, A. R., Huan, T., Brenner, D. A., Sirlin, C. B., Downes, M., Evans, R. M., & Loomba, R. (2020). A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell metabolism, 32(5), 901. https://doi.org/10.1016/j.cmet.2020.10.015
Oh, Tae Gyu, et al. "A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis." Cell metabolism vol. 32,5 (2020): 901. doi: https://doi.org/10.1016/j.cmet.2020.10.015
Oh TG, Kim SM, Caussy C, Fu T, Guo J, Bassirian S, Singh S, Madamba EV, Bettencourt R, Richards L, Yu RT, Atkins AR, Huan T, Brenner DA, Sirlin CB, Downes M, Evans RM, Loomba R. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell Metab. 2020 Nov 03;32(5):901. doi: 10.1016/j.cmet.2020.10.015. PMID: 33147487; PMCID: PMC7891106.
Copy Download .nbib Format: NLM
Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches.

STAR protocols

Troutman TD, Bennett H, Sakai M, Seidman JS, Heinz S, Glass CK.
PMID: 33748781
STAR Protoc. 2021 Mar 10;2(1):100363. doi: 10.1016/j.xpro.2021.100363. eCollection 2021 Mar 19.

Significant advancements in understanding disease mechanisms can occur through combined analysis of next-generation sequencing datasets generated using purified cell populations. Here, we detail our optimized protocol for purification of mouse hepatic macrophages (or other liver non-parenchymal populations) suitable for...

Cite
Troutman TD, Bennett H, Sakai M, et al. Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches. STAR Protoc. 2021;2(1):100363doi: 10.1016/j.xpro.2021.100363.
Troutman, T. D., Bennett, H., Sakai, M., Seidman, J. S., Heinz, S., & Glass, C. K. (2021). Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches. STAR protocols, 2(1), 100363. https://doi.org/10.1016/j.xpro.2021.100363
Troutman, Ty D, et al. "Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches." STAR protocols vol. 2,1 (2021): 100363. doi: https://doi.org/10.1016/j.xpro.2021.100363
Troutman TD, Bennett H, Sakai M, Seidman JS, Heinz S, Glass CK. Purification of mouse hepatic non-parenchymal cells or nuclei for use in ChIP-seq and other next-generation sequencing approaches. STAR Protoc. 2021 Mar 10;2(1):100363. doi: 10.1016/j.xpro.2021.100363. eCollection 2021 Mar 19. PMID: 33748781; PMCID: PMC7960533.
Copy Download .nbib Format: NLM
Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice.

Aging cell

Palmieri M, Almeida M, Nookaew I, Gomez-Acevedo H, Joseph TE, Que X, Tsimikas S, Sun X, Manolagas SC, Witztum JL, Ambrogini E.
PMID: 34278710
Aging Cell. 2021 Aug;20(8):e13442. doi: 10.1111/acel.13442. Epub 2021 Jul 19.

Oxidized phospholipids (OxPLs) are pro-inflammatory molecules that affect bone remodeling under physiological conditions. Transgenic expression of a single-chain variable fragment (scFv) of the antigen-binding domain of E06, an IgM natural antibody that recognizes the phosphocholine (PC) moiety of OxPLs,...

Cite
Palmieri M, Almeida M, Nookaew I, et al. Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice. Aging Cell. 2021;20(8):e13442doi: 10.1111/acel.13442.
Palmieri, M., Almeida, M., Nookaew, I., Gomez-Acevedo, H., Joseph, T. E., Que, X., Tsimikas, S., Sun, X., Manolagas, S. C., Witztum, J. L., & Ambrogini, E. (2021). Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice. Aging cell, 20(8), e13442. https://doi.org/10.1111/acel.13442
Palmieri, Michela, et al. "Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice." Aging cell vol. 20,8 (2021): e13442. doi: https://doi.org/10.1111/acel.13442
Palmieri M, Almeida M, Nookaew I, Gomez-Acevedo H, Joseph TE, Que X, Tsimikas S, Sun X, Manolagas SC, Witztum JL, Ambrogini E. Neutralization of oxidized phospholipids attenuates age-associated bone loss in mice. Aging Cell. 2021 Aug;20(8):e13442. doi: 10.1111/acel.13442. Epub 2021 Jul 19. PMID: 34278710; PMCID: PMC8373359.
Copy Download .nbib Format: NLM
Erratum: Inflammation-induced IgA.

Nature

Shalapour S, Lin XJ, Bastian IN, Brain J, Burt AD, Aksenov AA, Vrbanac AF, Li W, Perkins A, Matsutani T, Zhong Z, Dhar D, Navas-Molina JA, Xu J, Loomba R, Downes M, Yu RT, Evans RM, Dorrestein PC, Knight R, Benner C, Anstee QM, Karin M.
PMID: 29168501
Nature. 2017 Dec 21;552(7685):430. doi: 10.1038/nature25028. Epub 2017 Nov 22.

This corrects the article DOI: 10.1038/nature24302.

Cite
Shalapour S, Lin XJ, Bastian IN, et al. Erratum: Inflammation-induced IgA. Nature. 2017;552(7685):430doi: 10.1038/nature25028.
Shalapour, S., Lin, X. J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., Zhong, Z., Dhar, D., Navas-Molina, J. A., Xu, J., Loomba, R., Downes, M., Yu, R. T., Evans, R. M., Dorrestein, P. C., Knight, R., Benner, C., Anstee, Q. M., & Karin, M. (2017). Erratum: Inflammation-induced IgA. Nature, 552(7685), 430. https://doi.org/10.1038/nature25028
Shalapour, Shabnam, et al. "Erratum: Inflammation-induced IgA." Nature vol. 552,7685 (2017): 430. doi: https://doi.org/10.1038/nature25028
Shalapour S, Lin XJ, Bastian IN, Brain J, Burt AD, Aksenov AA, Vrbanac AF, Li W, Perkins A, Matsutani T, Zhong Z, Dhar D, Navas-Molina JA, Xu J, Loomba R, Downes M, Yu RT, Evans RM, Dorrestein PC, Knight R, Benner C, Anstee QM, Karin M. Erratum: Inflammation-induced IgA. Nature. 2017 Dec 21;552(7685):430. doi: 10.1038/nature25028. Epub 2017 Nov 22. PMID: 29168501; PMCID: PMC8594569.
Copy Download .nbib Format: NLM
Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.

Nature

Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, Atkins AR, Olefsky JM, Mohammadi M, Downes M, Evans RM.
PMID: 25739500
Nature. 2015 Apr 16;520(7547):388. doi: 10.1038/nature14304. Epub 2015 Mar 04.

No abstract available.

Cite
Suh JM, Jonker JW, Ahmadian M, et al. Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 2015;520(7547):388doi: 10.1038/nature14304.
Suh, J. M., Jonker, J. W., Ahmadian, M., Goetz, R., Lackey, D., Osborn, O., Huang, Z., Liu, W., Yoshihara, E., van Dijk, T. H., Havinga, R., Fan, W., Yin, Y. Q., Yu, R. T., Liddle, C., Atkins, A. R., Olefsky, J. M., Mohammadi, M., Downes, M., & Evans, R. M. (2015). Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature, 520(7547), 388. https://doi.org/10.1038/nature14304
Suh, Jae Myoung, et al. "Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer." Nature vol. 520,7547 (2015): 388. doi: https://doi.org/10.1038/nature14304
Suh JM, Jonker JW, Ahmadian M, Goetz R, Lackey D, Osborn O, Huang Z, Liu W, Yoshihara E, van Dijk TH, Havinga R, Fan W, Yin YQ, Yu RT, Liddle C, Atkins AR, Olefsky JM, Mohammadi M, Downes M, Evans RM. Corrigendum: Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature. 2015 Apr 16;520(7547):388. doi: 10.1038/nature14304. Epub 2015 Mar 04. PMID: 25739500.
Copy Download .nbib Format: NLM
Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts.

Oncogenesis

Noel P, Hussein S, Ng S, Antal CE, Lin W, Rodela E, Delgado P, Naveed S, Downes M, Lin Y, Evans RM, Von Hoff DD, Han H.
PMID: 33168807
Oncogenesis. 2020 Nov 09;9(11):100. doi: 10.1038/s41389-020-00285-9.

The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) is highly heterogeneous, fibrotic, and hypovascular, marked by extensive desmoplasia and maintained by the tumor cells, cancer-associated fibroblasts (CAFs) and other stromal cells. There is an urgent need to identify and...

Cite
Noel P, Hussein S, Ng S, et al. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Oncogenesis. 2020;9(11):100doi: 10.1038/s41389-020-00285-9.
Noel, P., Hussein, S., Ng, S., Antal, C. E., Lin, W., Rodela, E., Delgado, P., Naveed, S., Downes, M., Lin, Y., Evans, R. M., Von Hoff, D. D., & Han, H. (2020). Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Oncogenesis, 9(11), 100. https://doi.org/10.1038/s41389-020-00285-9
Noel, Pawan, et al. "Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts." Oncogenesis vol. 9,11 (2020): 100. doi: https://doi.org/10.1038/s41389-020-00285-9
Noel P, Hussein S, Ng S, Antal CE, Lin W, Rodela E, Delgado P, Naveed S, Downes M, Lin Y, Evans RM, Von Hoff DD, Han H. Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts. Oncogenesis. 2020 Nov 09;9(11):100. doi: 10.1038/s41389-020-00285-9. PMID: 33168807; PMCID: PMC7653036.
Copy Download .nbib Format: NLM
Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity.

Proceedings of the National Academy of Sciences of the United States of America

Wang L, Oh TG, Magida J, Estepa G, Obayomi SMB, Chong LW, Gatchalian J, Yu RT, Atkins AR, Hargreaves D, Downes M, Wei Z, Evans RM.
PMID: 34446564
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2109517118.

In macrophages, homeostatic and immune signals induce distinct sets of transcriptional responses, defining cellular identity and functional states. The activity of lineage-specific and signal-induced transcription factors are regulated by chromatin accessibility and other epigenetic modulators. Glucocorticoids are potent antiinflammatory...

Cite
Wang L, Oh TG, Magida J, et al. Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity. Proc Natl Acad Sci U S A. 2021;118(35)doi: 10.1073/pnas.2109517118.
Wang, L., Oh, T. G., Magida, J., Estepa, G., Obayomi, S. M. B., Chong, L. W., Gatchalian, J., Yu, R. T., Atkins, A. R., Hargreaves, D., Downes, M., Wei, Z., & Evans, R. M. (2021). Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity. Proceedings of the National Academy of Sciences of the United States of America, 118(35), . https://doi.org/10.1073/pnas.2109517118
Wang, Liu, et al. "Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity." Proceedings of the National Academy of Sciences of the United States of America vol. 118,35 (2021). doi: https://doi.org/10.1073/pnas.2109517118
Wang L, Oh TG, Magida J, Estepa G, Obayomi SMB, Chong LW, Gatchalian J, Yu RT, Atkins AR, Hargreaves D, Downes M, Wei Z, Evans RM. Bromodomain containing 9 (BRD9) regulates macrophage inflammatory responses by potentiating glucocorticoid receptor activity. Proc Natl Acad Sci U S A. 2021 Aug 31;118(35). doi: 10.1073/pnas.2109517118. PMID: 34446564; PMCID: PMC8536317.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries